Methylphenidate in Treatment of ADHD and Comorbid Chronic Tic Disorder
Abstract
The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention deficit hyperactivity disorder (ADHD) in children (ages 6-12 years) with Tourette's syndrome (96%) or chronic motor tic disorder (4%) were evaluated at State University of New York, Stony Brook.
DOI: https://doi.org/10.15844/pedneurbriefs-21-7-3 | Journal eISSN: 2166-6482
Language: English
Page range: 51 - 52
Published on: Jul 1, 2007
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2007 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.